This ppt describes on neuroleptanalgesia which is used for the chemical restraint of large animals. It also contains various combinations of neuroleptanalgesics. Neuroleptanalgesia is a combination of neurolept/ tranquiliser and an opiod analgesic.
2. Analgesia: - absence of pain
Tranquilisation: - state of behavioral change where in
anxiety is relieved & patient is relaxed, although
aware of its surroundings
10/28/20202 CNS PHARMACOLOGY
ANALGESICS
NEUROLEPT/
TRANQUILISER
NEUROLEPTANALGESICS
3. NEUROLEPTANALGESIA
A state of CNS depression & analgesia
Characterised by profound sedation, immobilisation,
intense analgesia without loss of consciousness
Introduced by De Castro & Mundeleer (1959) as
"anesthcsie sans barbituriques"
Became popular in Europe as "an alternative to
general anesthesia" (Nilsson & Janssen, 1961)
10/28/20203 CNS PHARMACOLOGY
4. Body becomes flaccid
Slowing down of bodily functions such as respiration
Also has adrenergic blocking, antiemetic,
antifibrillatic & anticonvulsant activities
Similar to but not equal to a light plane of anesthesia
1960’s- Phenoperidine & Haloperidol
Early 1980’s- replaced by Fentanyl & Droperidol
10/28/20204 CNS PHARMACOLOGY
Effects show marked variation, so data on one
animal cannot be transposed on other animals
5. ADVANTAGES
Produce more deeper & more reliable sedation
Produce more reliable analgesia & less marked
respiratory depression
Neuroleptic component abolishes the emetic effect
and lessens the bradycardia & bradyarrhythmia
produced by opioid analgesics (dogs)
Produce a stage of immobilisation suitable for
chemical restraint of wild & exotic animals
10/28/20205 CNS PHARMACOLOGY
6. INDICATIONS
In minor surgical procedures
In diagnostic procedures
Adjunct to local anesthetic
Used as premedication
Chemical restraint of wild & ferocious animals
10/28/20206 CNS PHARMACOLOGY
8. FENTANYL & DROPERIDOL
Fentanyl- potent opioid agonist
Droperidol- butyrephenone neuroleptic sedative
In a ratio 1:50- INNOVAR- VET
Droperidol potentiates the analgesic effect of Fentanyl
Droperidol is a potent D₂ receptor antagonist with Histamine
& 5HT antagonist activity
Possess central antiemetic action, reduce motor tone &
causes tranquilisation & sedation
Fentanyl acts at μ opioid receptors & produce analgesia
10/28/20208 CNS PHARMACOLOGY
9. Combined effect in dogs include a decreased heart
rate secondary to increased vagal tone & decrease in
arterial BP
In cats heart rate is increased with decrease in BP
PHARMACOKINETICS
Onset of action within 30-40 min
Remain sedated for hours
Metabolised in liver
Eliminated in urine
10/28/20209 CNS PHARMACOLOGY
10. SIDE EFFECTS
Are dose dependent- overdosage
Bradycardia, respiratory depression, salivation, nystagmus &
defecation
Wood chest syndrome in dogs & humans after rapid i/v
Thoracic musculature is rigid & interferes with normal
ventilatory function
Attributed to Fentanyl & is reversed by Naloxone
CNS stimulation, ataxia & abnormal behavior in pigs
Irritation & pain at site of injection
Overdosage- profound respiratory & CNS depression
10/28/202010 CNS PHARMACOLOGY
11. CONTRAINDICATIONS
Not used in food animals
Perivascular injection avoided- tissue irritation
Not recommended in cats, horses & ruminants – CNS
stimulation
Should not be used along with barbiturates in C-section-
hazardous to neonates
Administration of Atropine prior can prevent bradycardia
& salivation
Approved for use only in dogs
@0.1-0.15 ml/Kg im & 0.04-0.08ml/Kg iv
10/28/202011 CNS PHARMACOLOGY
0.4mg Fentanyl &
20mg Droperidol in
each ml
12. ETORPHINE &
ACEPROMAZINE
Used for immobilisation of various domestic & exotic
species
Etorphine- Opioid agonist
Acepromazine- phenothiazine tranquiliser
Acepromazine is a potent dopamine receptor antagonist
with some histamine, serotonin, muscarinic & α
adrenergic receptor blocking actions
Etorphine is an opioid agonist widely used to
immobilize large domestic & wild animals such as
elephants 10/28/202012
13. Recommended in domestic animals such as horses,
pigs, cattle & sheep
Combination causes marked & persistent
tachycardia, transient rise in BP, increased muscle
tone & mydriasis
Highly toxic to humans- should wear gloves
Immobilisation should not be used without
availability of an opioid antagonist Naloxone
10/28/202013 CNS PHARMACOLOGY
14. Highly potent neuroleptanalgesic supplied
along with antagonist Diprenorphine
10/28/202014 CNS PHARMACOLOGY
Contain 2.45mg/ml Etorphine with
Acepromazine 10mg/ml in IMMOBILON
& 3mg/ml Diprenorphine in REVIVON
17. NEUROLEPTANESTHESIA
Concurrent administration of 65-70% N₂O to
neuroleptanalgesics
State of amnesia is produced
Patient completely detached from environment
Loss of consciousness
Loss of ability to obey commands & communicate
Inability to move or change position
Fentanyl + Droperidol + N₂O
10/28/202017 CNS PHARMACOLOGY